S
Suzhou Weibang Zhendian Optoelectronics Technology
Optical & acoustic imaging and sensing technology for surgical guidiance and diangosis
About Suzhou Weibang Zhendian Optoelectronics Technology
Vibronix Inc. specializes in developing advanced medical imaging devices, particularly for ultrasound-guided procedures. The company's flagship product, AcuSee, is a guidance system that assists in visualizing and displaying the trajectory and orientation of instruments such as biopsy needles, aspiration needles, and ablation needles within ultrasound images. This technology aims to reduce the difficulty, improve the accuracy, and shorten the learning curve for ultrasound-guided procedures. Vibronix operates primarily in the medical technology market, serving healthcare providers and medical professionals who require precise imaging solutions for interventional procedures. The company's business model revolves around the development, FDA approval, and commercialization of its innovative medical devices. Revenue is generated through the sale of these devices to hospitals, clinics, and other healthcare facilities. Vibronix's competitive edge lies in its ability to integrate cutting-edge optical spectroscopic imaging techniques with practical medical applications, a feat achieved under the scientific guidance of renowned experts like Dr. Ji Xin Cheng. The company continues to push the boundaries of medical imaging technology, aiming to bring science fiction concepts like the tricorder from Star Trek into real-world medical practice.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Suzhou Shi, China
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 70.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Spinout, DT and LS, science-based
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Computer Vision
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2024 | $14M | $55M | Founder H Fund · Tao Capital · Frees Fund · Wuxi Venture Capital Group | ↗ |
| EARLY VCEquity / VC | Aug 2020 | $1.4M | $5.6M | Undisclosed | — |
Growth signals
Latest recorded traffic for Suzhou Weibang Zhendian Optoelectronics Technology is 720 monthly website visits, up 46.9% over the last three months. Suzhou Weibang Zhendian Optoelectronics Technology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A4 investors entered at this stage
Tao Capital- FFFounder H Fund
Frees Fund- WGWuxi Venture Capital Group
Other known investors4 additional known investors
Purdue University
Elevate Ventures
Plug and Play
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Suzhou Weibang Zhendian Optoelectronics Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Suzhou Weibang Zhendian Optoelectronics Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







